BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22943385)

  • 1. Carboplatin AUC 10 for IGCCCG good prognosis metastatic seminoma.
    Tookman L; Rashid S; Matakidou A; Phillips M; Wilson P; Ansell W; Jamal-Hanjani M; Chowdhury S; Harland S; Sarwar N; Oliver T; Powles T; Shamash J
    Acta Oncol; 2013 Jun; 52(5):987-93. PubMed ID: 22943385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A medical research council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma. MRC Testicular Tumour Working Party.
    Horwich A; Oliver RT; Wilkinson PM; Mead GM; Harland SJ; Cullen MH; Roberts JT; Fossa SD; Dearnaley DP; Lallemand E; Stenning SP;
    Br J Cancer; 2000 Dec; 83(12):1623-9. PubMed ID: 11104556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastatic seminoma treated with either single agent carboplatin or cisplatin-based combination chemotherapy: a pooled analysis of two randomised trials.
    Bokemeyer C; Kollmannsberger C; Stenning S; Hartmann JT; Horwich A; Clemm C; Gerl A; Meisner C; Rückerl CP; Schmoll HJ; Kanz L; Oliver T
    Br J Cancer; 2004 Aug; 91(4):683-7. PubMed ID: 15266338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk-adapted management for patients with clinical stage I seminoma: the Second Spanish Germ Cell Cancer Cooperative Group study.
    Aparicio J; Germà JR; García del Muro X; Maroto P; Arranz JA; Sáenz A; Barnadas A; Dorca J; Gumà J; Olmos D; Bastús R; Carles J; Almenar D; Sánchez M; Paz-Ares L; Satrústegui JJ; Mellado B; Balil A; López-Brea M; Sánchez A;
    J Clin Oncol; 2005 Dec; 23(34):8717-23. PubMed ID: 16260698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy as an alternative to radiotherapy in the treatment of stage IIA and IIB testicular seminoma: a Spanish Germ Cell Cancer Group Study.
    Garcia-del-Muro X; Maroto P; Gumà J; Sastre J; López Brea M; Arranz JA; Lainez N; Soto de Prado D; Aparicio J; Piulats JM; Pérez X; Germá-Lluch JR
    J Clin Oncol; 2008 Nov; 26(33):5416-21. PubMed ID: 18936476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective multicentre study of carboplatin monotherapy for clinical stage I seminoma.
    Steiner H; Scheiber K; Berger AP; Rein P; Hobisch A; Aufderklamm J; Pilloni S; Stoehr B; Aigner F; Fritzer A; Zangerl F
    BJU Int; 2011 Apr; 107(7):1074-9. PubMed ID: 21438975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An alternative treatment regimen of advanced seminoma with carboplatin, etoposide, and bleomycin instead of cisplatin-based therapy.
    Giesen E; Mager A; van Tinteren H; Rodenhuis S; Kerst JM
    Urol Oncol; 2013 Jan; 31(1):110-4. PubMed ID: 21458311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carboplatin and cyclophosphamide in the treatment of metastatic seminoma.
    Mardiak J; Sálek T; Sycova-Milá Z; Sufliarsky J; Baláz M; Koza I
    Neoplasma; 2000; 47(4):244-7. PubMed ID: 11043830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Qualitative Analysis of the Impact of Carboplatin AUC 10 on Physical, Work Functioning and Bone Marrow Toxicity Among Seminoma Patients - A Single-centre Experience.
    Milic M; Hall M; Hawkins A; Gogbashian A; Rustin G; Sharma A
    In Vivo; 2019; 33(1):233-237. PubMed ID: 30587629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant Carboplatin Treatment in 115 Patients With Stage I Seminoma: Retrospective Multicenter Survey.
    Diminutto A; Basso U; Maruzzo M; Morelli F; De Giorgi U; Perin A; Fraccon AP; Lo Re G; Rizzi A; Sava T; Fornarini G; Valcamonico F; Zustovich F; Massari F; Zanardi E; Roma A; Zattoni F; Zagonel V
    Clin Genitourin Cancer; 2016 Apr; 14(2):e161-9. PubMed ID: 26775721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two cycles of cisplatin-based chemotherapy for low-volume stage II seminoma: results of a retrospective, single-center case series.
    Pichler R; Leonhartsberger N; Stöhr B; Horninger W; Steiner H
    Chemotherapy; 2012; 58(5):405-10. PubMed ID: 23296381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A risk-adapted study of cisplatin and etoposide, with or without ifosfamide, in patients with metastatic seminoma: results of the GETUG S99 multicenter prospective study.
    Fizazi K; Delva R; Caty A; Chevreau C; Kerbrat P; Rolland F; Priou F; Geoffrois L; Rixe O; Beuzeboc P; Malhaire JP; Culine S; Aubelle MS; Laplanche A
    Eur Urol; 2014 Feb; 65(2):381-6. PubMed ID: 24094847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase II study of carboplatin AUC-10 guided by positron emission tomography-defined metabolic response in metastatic seminoma.
    Shamash J; Syed R; Sarker SJ; Sarwar N; Sharma A; Mutsvangwa K; Coetzee C; Wilson P; Rustin GJ
    Eur J Cancer; 2019 Jul; 115():128-135. PubMed ID: 31136925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-agent carboplatin AUC10 in metastatic seminoma: A multi-centre UK study of 216 patients.
    Alifrangis C; Sharma A; Chowdhury S; Duncan S; Milic M; Gogbashian A; Agarwal S; Sahdev A; Wilson P; Harland S; Stoneham S; Lockley M; Rustin G; Oliver T; Berney D; Shamash J
    Eur J Cancer; 2022 Mar; 164():105-113. PubMed ID: 33041185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Single agent carboplatin therapy for advanced seminoma].
    Kawakita M; Fukuzawa S; Terachi T; Hashimura T; Takeuchi H; Yoshida O
    Hinyokika Kiyo; 1994 Jun; 40(6):493-7. PubMed ID: 8073956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treating IIA/B seminoma with combination carboplatin and radiotherapy.
    Gilbert DC; Vanas NJ; Beesley S; Bloomfield D; Money-Kyrle J; Norman A; Dearnaley D; Horwich A; Huddart RA
    J Clin Oncol; 2009 Apr; 27(12):2101-2; author reply 2102-3. PubMed ID: 19289608
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk-adapted treatment in clinical stage I testicular seminoma: the third Spanish Germ Cell Cancer Group study.
    Aparicio J; Maroto P; del Muro XG; Gumà J; Sánchez-Muñoz A; Margelí M; Doménech M; Bastús R; Fernández A; López-Brea M; Terrassa J; Meana A; del Prado PM; Sastre J; Satrústegui JJ; Gironés R; Robert L; Germà JR
    J Clin Oncol; 2011 Dec; 29(35):4677-81. PubMed ID: 22042940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination carboplatin and radiotherapy in the management of stage II testicular seminoma: comparison with radiotherapy treatment alone.
    Patterson H; Norman AR; Mitra SS; Nicholls J; Fisher C; Dearnaley DP; Horwich A; Mason MD; Huddart RA
    Radiother Oncol; 2001 Apr; 59(1):5-11. PubMed ID: 11295200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single agent carboplatin for CS IIA/B testicular seminoma. A phase II study of the German Testicular Cancer Study Group (GTCSG).
    Krege S; Boergermann C; Baschek R; Hinke A; Pottek T; Kliesch S; Dieckmann KP; Albers P; Knutzen B; Weinknecht S; Schmoll HJ; Beyer J; Ruebben H;
    Ann Oncol; 2006 Feb; 17(2):276-80. PubMed ID: 16254023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carboplatin for stage I seminoma and the sword of Damocles.
    Loehrer PJ; Bosl GJ
    J Clin Oncol; 2005 Dec; 23(34):8566-9. PubMed ID: 16260692
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.